Display Settings:

Format

Send to:

Choose Destination

    Fundam Clin Pharmacol. 2009 Oct;23(5):539-41. Epub 2009 Aug 6.

    Recurrent dysosmia induced by pyrazinamide.

    El Aïdli S, Kastalli S, Zaïem A, Lakhoua G, Rejeibi I, Loueslati MH, Daghfous R, Belkahia C.

    Centre National de Pharmacovigilance, Recueil et Analyse des Effets Indésirables, Tunis, Tunisia.

    Pyrazinamide can have adverse effects such as hepatic toxicity, hyperuricemia or digestive disorders. In rare cases, alterations in taste and smell function have been reported for pyrazinamide when combined with other drugs. We report a case of reversible olfactory disorder related to pyrazinamide in a woman, with a positive rechallenge. The patient presented every day a sensation of smelling something burning 15 min after drug intake. Dysosmia disappeared completely after pyrazinamide withdrawal and recurred after its rechallenge. The case was reported to the Tunisian Centre of Pharmacovigilance.

    PMID: 19674115 [PubMed - in process]

    Supplemental Content

    Click here to read Click here to read

    Patient drug information

    • Pyrazinamide

      Pyrazinamide kills or stops the growth of certain bacteria that cause tuberculosis (TB). It is used with other drugs to treat tuberculosis.